HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis

BACKGROUND AND AIMS: HCV cure reduces but does not eliminate the risk of HCC. HCC surveillance is recommended in populations where the incidence exceeds 1.5% per year. In cirrhosis, HCC surveillance should continue after HCV cure, although it is uncertain if this should be indefinite. For patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockart, Ian, Yeo, Malcolm G. H., Hajarizadeh, Behzad, Dore, Gregory J., Danta, Mark, Abe, Kazumichi, Carrat, Fabrice, Lusivika‐Nzinga, Clovis, Degasperi, Elisabetta, Di Marco, Vito, Hou, Jinlin, Howell, Jessica, Janjua, Naveed Z, Wong, Stanley, Kumada, Takashi, Lleo, Ana, Persico, Marcello, Lok, Anna S, Wei, Lai, Yang, Ming, Nabatchikova, Ekaterina, Nguyen, Mindie H, Antonio Pineda, Juan, Reig, María, Shiha, Gamal, Yu, Ming‐Lung, Tsai, Pei‐Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303770/
https://www.ncbi.nlm.nih.gov/pubmed/35030279
http://dx.doi.org/10.1002/hep.32341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303770/
https://www.ncbi.nlm.nih.gov/pubmed/35030279
http://dx.doi.org/10.1002/hep.32341

Ejemplares similares